Publication Name	World Journal of Meta-Analysis
Manuscript ID	27773
Country	India

Received	2016-06-16 10:21
Peer-Review Started	2016-06-16 16:40
To Make the First Decision	2016-07-27 08:22
Return for Revision	2016-07-29 10:33
Revised	2016-08-06 19:48
Second Decision	2017-02-09 18:16
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2017-02-20 15:12
Articles in Press	2017-02-20 15:12
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-04-17 14:08
Publish the Manuscript Online	2017-04-26 11:29

ISSN	2308-3840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Meta-Analysis
Article Title	Statin use and risk of cancer: An overview of meta-analyses
Manuscript Source	Invited Manuscript
All Author List	Krishna Undela, Chirag S Shah and Raj K Mothe
Funding Agency and Grant Number
Corresponding Author	Krishna Undela, Lecturer, Department of Pharmacy Practice, JSS College of Pharmacy, Jagadguru Sri Shivarathreeshwara University, SS Nagara, Mysuru 570015, India. krishnaundela@jssuni.edu.in
Key Words	Statin; Cancer; Meta-analysis
Core Tip	Statins are one of the most commonly prescribed pharmaceutical agents worldwide and atorva­statin remained the largest source of spending in the class. In recent years, emerging experimental evidence suggests that statins may have a potential role in cancer chemoprevention. However, a large number of randomized controlled trials and observational studies published to examine the association between statin use and risk of site specific cancers were given conflicting results. This overview of meta-analyses with variable quality has been shown that the statins may have a potential role in cancer chemoprevention and reduce the risk of colorectal (8%-12%), gastric (27%-44%), hematological (19%), liver (37%-42%), oesophageal (14%-28%), ovarian (21%) and prostate cancer (7%).
Publish Date	2017-04-26 11:29
Citation	Undela K, Shah CS, Mothe RK. Statin use and risk of cancer: An overview of meta-analyses. World J Meta-Anal 2017; 5(2): 41-53
URL	http://www.wjgnet.com/2308-3840/full/v5/i2/41.htm
DOI	http://dx.doi.org/10.13105/wjma.v5.i2.41

Full Article (PDF)	WJMA-5-41.pdf
Full Article (Word)	WJMA-5-41.doc
Manuscript File	27773-Review.docx
Answering Reviewers	27773-Answering reviewers.pdf
Audio Core Tip	27773-Audio core tip.mp3
Biostatistics Review Certificate	27773-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	27773-Conflict-of-interest statement.pdf
Copyright License Agreement	27773-Copyright assignment.pdf
Supplementary Material	27773-Supplementary material.pdf
Peer-review Report	27773-Peer-review(s).pdf
Scientific Misconduct Check	27773-Scientific misconduct check.pdf
Scientific Editor Work List	27773-Scientific editor work list.pdf